SCHEMBL4100057

SCHEMBL4100057

CN(c1ccc(Cl)cc1)S(=O)(=O)Nc1ccc2nc(N[C@@H]3CCc4ccccc43)ccc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FADS1 O60427 1/20 0.41
GLP1R P43220 1/20 0.39
PFKFB3 Q16875 5/20 0.37
LMNA P02545 2/20 0.36
KDM4E B2RXH2 2/20 0.36
TSHR P16473 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
ALOX15 P16050 1/20 0.36
SCN1A P35498 2/20 0.36
SCN5A Q14524 2/20 0.36
SCN8A Q9UQD0 2/20 0.36
BRD4 O60885 1/20 0.35
NAE1 Q13564 1/20 0.35
UBA3 Q8TBC4 1/20 0.35
POLB P06746 1/20 0.35
HTT P42858 1/20 0.35
NSD2 O96028 2/20 0.35
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.35
TP53 P04637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4105895 0.92 PFKFB3 (0.37) FADS1GLP1RPFKFB3LMNAKDM4E
SCHEMBL4101413 0.91 FADS1 (0.46) FADS1GLP1RPFKFB3LMNAKDM4E
SCHEMBL3401353 0.91 PFKFB3 (0.41) FADS1GLP1RPFKFB3LMNAKDM4E
SCHEMBL4106792 0.90 HPGDS (0.43) GLP1RPFKFB3LMNAKDM4ETSHR
SCHEMBL4117077 0.88 FADS1 (0.38) FADS1GLP1RPFKFB3LMNAKDM4E
SCHEMBL3412817 0.88 SMN1; SMN2 (0.42) FADS1GLP1RPFKFB3LMNAKDM4E
SCHEMBL4097398 0.85 KDM4E (0.38) FADS1GLP1RPFKFB3LMNAKDM4E
SCHEMBL4104986 0.83 LMNA (0.39) FADS1GLP1RPFKFB3LMNAKDM4E
SCHEMBL4097503 0.82 MET (0.39) FADS1GLP1RPFKFB3LMNAKDM4E
SCHEMBL3403995 0.82 FADS1 (0.55) FADS1GLP1RPFKFB3LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8188284-B2 2-aminoquinolines HOFFMAN-LA ROCHE INC. (US) 2012-05-29 US claimed
US-20090227583-A1 2-AMINOQUINOLINES F. HOFFMANN-LA ROCHE AG, A SWISS COMPANY (CH) 2009-09-10 US claimed
US-8188284-B2 2-aminoquinolines HOFFMAN-LA ROCHE INC. (US) 2012-05-29 US disclosed
US-20090227583-A1 2-AMINOQUINOLINES F. HOFFMANN-LA ROCHE AG, A SWISS COMPANY (CH) 2009-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227583-A1 2-AMINOQUINOLINES HTR5A, HTR2C, HTR2B FADS1 2801/4885GLP1R 451/4885PFKFB3 3870/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.